日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer

微小残留病灶可增强可切除非小细胞肺癌的预后分层,其效果优于病理反应。

Provencio, Mariano; Serna-Blasco, Roberto; Nadal, Ernest; González Larriba, José Luis; Martínez-Martí, Alex; Bernabé Caro, Reyes; Bosch-Barrera, Joaquim; Calvo, Virginia; Insa Molla, Amelia; Reguart, Noemí; de Castro Carpeño, Javier; Aguado de la Rosa, Carlos; Palmero Sanchez, Ramón; Hernando Trancho, Florentino; Martín-López, Javier; Rodríguez-Festa, Alejandro; Mediavilla-Medel, Pilar; Lázaro, Martín; Hayes, Jim; Cruz-Bermúdez, Alberto; Massutí, Bartomeu; Romero, Atocha

Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

解码非小细胞肺癌围手术期化疗免疫疗法完全病理反应的 B 细胞特征。

Sierra-Rodero Belén, Gil-González Ángeles, Molina-Alejandre Marta, Nadal Ernest, Calvo Virginia, Lázaro Martín, Insa Amelia, Massuti Bartomeu, Martinez Marti Alex, de Castro Javier, García Campelo Rosario, González Larriba Jose Luis, Bernabé Reyes, Dómine Manuel, Ponce Aix Santiago, Cobo Manuel, Camps Carlos, Reguart Noemi, Bosch-Barrera Joaquím, Majem Margarita, Aguilar Andres, Palmero Ramón, Blanco Clemente Mariola, Martín-López Javier, Muñoz-Viana Rafael, Megías Diego, Gutiérrez-Escobedo Juan Manuel, Martínez-Toledo Cristina, Cruz-Bermúdez Alberto, Provencio Mariano

A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250)

一项 II 期、多中心、开放标签、单臂研究,评估 berzosertib 联合拓扑替康治疗复发性铂耐药小细胞肺癌患者的疗效(DDRiver SCLC 250)。

Navarro, A; Thomas, A; Cheng, Y; Chen, Y; Reguart, N; Yoshida, T; Cousin, S; Dong, X; Yamamoto, N; Cappuzzo, F; Hallwachs, R; Bolleddula, J; Sarholz, B; Grombacher, T; Otte, M; Gounaris, I; Ferrer, J; Moulin, C; Paz-Ares, L

Oncology with common sense: beyond biologistic and pharmacological models

以常识为基础的肿瘤学:超越生物学和药理学模型

Lastra, Rodrigo; Iranzo, Patricia; Benítez-Fuentes, Javier-David; Callejo, Ana; Cruellas, Mara; Gómez Ulla, Jacobo; Pimentel, Isabel; Pérez-Gracia, José Luis; Ramos, Marta; Gil Moncayo, Francisco; Álvarez Alejandro, María; Gascón, Marta; Martínez Recio, Sergio; Rivero, Pilar; Bartolomé, Jorge; Lázaro Sánchez, Antonio David; Fernández Garay, David; de Luna Aguilar, Alicia; Lorenzo Lorenzo, Isabel; Brunet, Joan; Reguart, Noemi; Trapani, Dario

Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy

tarlatamab治疗第1周期采用6-8小时门诊监测与48小时住院监测的安全性比较:DeLLphi-300 1期子研究

Chiang, A C; Olmedo Garcia, M E; Carlisle, J W; Dowlati, A; Reguart, N; Felip, E; Jost, P J; Steeghs, N; Stec, R; Gadgeel, S M; Loong, H H; Jiang, W; Hamidi, A; Parkes, A; Paz-Ares, L

Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer

针对BCL-2家族的新型选择性策略可提高ALK重排非小细胞肺癌的临床疗效

Fernando Martín ,Clara Alcon ,Elba Marín ,Paula Morales-Sánchez ,Albert Manzano-Muñoz ,Sherley Díaz ,Mireia García ,Josep Samitier ,Albert Lu ,Alberto Villanueva ,Noemí Reguart ,Cristina Teixido ,Joan Montero

Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer

KRAS G12C 突变型晚期非小细胞肺癌中 sotorasib 相关不良事件的汇总安全性分析和管理

Skoulidis, Ferdinandos; Li, Bob T; Hochmair, Maximilian; Govindan, Ramaswamy; Vincent, Mark; van der Wekken, Anthonie J; Reguart Aransay, Noemi; O'Byrne, Kenneth J; Girard, Nicolas; Griesinger, Frank; Nishio, Makoto; Häfliger, Simon; Lindsay, Colin; Reinmuth, Niels; Paulus, Astrid; Papakotoulas, Pavlos; Kim, Sang-We; Ferreira, Carlos Gil; Pasello, Giulia; Duruisseaux, Michael; Gennatas, Spyridon; Dimou, Anastasios; Mehta, Bhakti; Kormany, William; Nduka, Chidozie; Sylvester, Brooke E; Ardito-Abraham, Christine; Wang, Yang; de Langen, Adrianus Johannes

Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study)

非小细胞肺癌驱动致癌基因改变的频率及欧洲室内氡暴露量估计(欧洲氡研究)

García-Pardo, Miguel; García de Herreros, Marta; Auclin, Edouard; Ferriol-Galmes, Miquel; Laguna, Juan Carlos; Gorría, Teresa; Caravaca, Gerard; Sart, Joan; Albarrán-Artahona, Víctor; López-Castro, Rafael; Teixidó, Cristina; Castellano, Giancarlo; Martínez Bedmar, Alex; Arcocha, Ainara; Alcolea, Laura; Jiménez, Manuel; Bernabeu, Mario; Delgado-Cano, David; Navarro, Alejandro; Prat, Aleix; Reguart, Noemí; Elio, Javier; Garrido, Pilar; Leighl, Natasha B; Besse, Benjamin; Mezquita, Laura

Multimodal prehabilitation to prevent loss of cardiorespiratory fitness in patients with locally advanced lung cancer undergoing chemoimmunotherapy: protocol for a non-randomized multicentre study

针对接受化疗免疫治疗的局部晚期肺癌患者,采用多模式预康复预防心肺功能下降:一项非随机多中心研究方案

Chen, Yu Xiao; Sebio-Garcia, Raquel; Arguis, Maria Jose; Reguart, Noemi; Arcocha, Ainara; Navarro, Alejandro; Navarro-Ripoll, Ricard; Boujibar, Fairuz; Muñoz-Borrajo, Silvia; Boada, Marc; Ureña, Anna; Guirao, Angela; Sisó, Marina; Cardeña-Gutiérrez, Ana; Pérez-García, Raquel; Bello, Irene; Martínez-Pallí, Graciela

Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence

回顾性队列研究:心包内注射顺铂降低恶性心包积液复发风险

Muñoz-Carrillo, Francisco Javier; Reyes, Roxana Maribel; Pesántez, David; Carrera, Gemma; Cascos, Enric; Castro, Pedro; Fernández-Méndez, Sara; Font, Carme; González-Aguado, Laura; Grafiá, Ignacio; Llavata, Lucía; Monge-Escartín, Inés; Padrosa, Joan; Reguart, Noemí; Téllez, Adrián; Tuca, Albert; Viladot, Margarita; Zamora-Martínez, Carles; Amorós-Reboredo, Patrícia; Marco-Hernández, Javier